ID   NR1D1_RAT               Reviewed;         615 AA.
AC   Q63503; Q6P6S7;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 2.
DT   24-JUL-2024, entry version 173.
DE   RecName: Full=Nuclear receptor subfamily 1 group D member 1;
DE   AltName: Full=Rev-erbA-alpha;
DE   AltName: Full=V-erbA-related protein 1;
DE            Short=EAR-1;
GN   Name=Nr1d1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 11-615.
RX   PubMed=2542765; DOI=10.1128/mcb.9.3.1128-1136.1989;
RA   Lazar M.A., Hodin R.A., Darling D.S., Chin W.W.;
RT   "A novel member of the thyroid/steroid hormone receptor family is encoded
RT   by the opposite strand of the rat c-erbA alpha transcriptional unit.";
RL   Mol. Cell. Biol. 9:1128-1136(1989).
RN   [3]
RP   INTERACTION WITH OPHN1.
RX   PubMed=21874017; DOI=10.1038/nn.2911;
RA   Valnegri P., Khelfaoui M., Dorseuil O., Bassani S., Lagneaux C.,
RA   Gianfelice A., Benfante R., Chelly J., Billuart P., Sala C., Passafaro M.;
RT   "A circadian clock in hippocampus is regulated by interaction between
RT   oligophrenin-1 and Rev-erbalpha.";
RL   Nat. Neurosci. 14:1293-1301(2011).
RN   [4]
RP   FUNCTION.
RX   PubMed=22425774; DOI=10.1016/j.bbrc.2012.02.164;
RA   Chen H., Chu G., Zhao L., Yamauchi N., Shigeyoshi Y., Hashimoto S.,
RA   Hattori M.A.;
RT   "Rev-erbalpha regulates circadian rhythms and StAR expression in rat
RT   granulosa cells as identified by the agonist GSK4112.";
RL   Biochem. Biophys. Res. Commun. 420:374-379(2012).
RN   [5]
RP   INDUCTION.
RX   PubMed=22549838; DOI=10.1038/ncomms1812;
RA   Negoro H., Kanematsu A., Doi M., Suadicani S.O., Matsuo M., Imamura M.,
RA   Okinami T., Nishikawa N., Oura T., Matsui S., Seo K., Tainaka M., Urabe S.,
RA   Kiyokage E., Todo T., Okamura H., Tabata Y., Ogawa O.;
RT   "Involvement of urinary bladder Connexin43 and the circadian clock in
RT   coordination of diurnal micturition rhythm.";
RL   Nat. Commun. 3:809-809(2012).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Transcriptional repressor which coordinates circadian rhythm
CC       and metabolic pathways in a heme-dependent manner. Integral component
CC       of the complex transcription machinery that governs circadian
CC       rhythmicity and forms a critical negative limb of the circadian clock
CC       by directly repressing the expression of core clock components BMAL1,
CC       CLOCK and CRY1. Also regulates genes involved in metabolic functions,
CC       including lipid and bile acid metabolism, adipogenesis, gluconeogenesis
CC       and the macrophage inflammatory response. Acts as a receptor for heme
CC       which stimulates its interaction with the NCOR1/HDAC3 corepressor
CC       complex, enhancing transcriptional repression. Recognizes two classes
CC       of DNA response elements within the promoter of its target genes and
CC       can bind to DNA as either monomers or homodimers, depending on the
CC       nature of the response element. Binds as a monomer to a response
CC       element composed of the consensus half-site motif 5'-[A/G]GGTCA-3'
CC       preceded by an A/T-rich 5' sequence (RevRE), or as a homodimer to a
CC       direct repeat of the core motif spaced by two nucleotides (RevDR-2).
CC       Acts as a potent competitive repressor of ROR alpha (RORA) function and
CC       regulates the levels of its ligand heme by repressing the expression of
CC       PPARGC1A, a potent inducer of heme synthesis. Regulates lipid
CC       metabolism by repressing the expression of APOC3 and by influencing the
CC       activity of sterol response element binding proteins (SREBPs);
CC       represses INSIG2 which interferes with the proteolytic activation of
CC       SREBPs which in turn govern the rhythmic expression of enzymes with key
CC       functions in sterol and fatty acid synthesis. Regulates gluconeogenesis
CC       via repression of G6PC1 and PEPCK and adipocyte differentiation via
CC       repression of PPARG. Regulates glucagon release in pancreatic alpha-
CC       cells via the AMPK-NAMPT-SIRT1 pathway and the proliferation, glucose-
CC       induced insulin secretion and expression of key lipogenic genes in
CC       pancreatic-beta cells. Positively regulates bile acid synthesis by
CC       increasing hepatic expression of CYP7A1 via repression of NR0B2 and
CC       NFIL3 which are negative regulators of CYP7A1. Modulates skeletal
CC       muscle oxidative capacity by regulating mitochondrial biogenesis and
CC       autophagy; controls mitochondrial biogenesis and respiration by
CC       interfering with the STK11-PRKAA1/2-SIRT1-PPARGC1A signaling pathway.
CC       Represses the expression of SERPINE1/PAI1, an important modulator of
CC       cardiovascular disease and the expression of inflammatory cytokines and
CC       chemokines in macrophages. Represses gene expression at a distance in
CC       macrophages by inhibiting the transcription of enhancer-derived RNAs
CC       (eRNAs). Plays a role in the circadian regulation of body temperature
CC       and negatively regulates thermogenic transcriptional programs in brown
CC       adipose tissue (BAT); imposes a circadian oscillation in BAT activity,
CC       increasing body temperature when awake and depressing thermogenesis
CC       during sleep. In concert with NR2E3, regulates transcriptional networks
CC       critical for photoreceptor development and function. In addition to its
CC       activity as a repressor, can also act as a transcriptional activator
CC       (By similarity). In the ovarian granulosa cells acts as a
CC       transcriptional activator of STAR which plays a role in steroid
CC       biosynthesis (PubMed:22425774). In collaboration with SP1, activates
CC       GJA1 transcription in a heme-independent manner (By similarity).
CC       Represses the transcription of CYP2B10, CYP4A10 and CYP4A14 (By
CC       similarity). Represses the transcription of CES2 (By similarity).
CC       Represses and regulates the circadian expression of TSHB in a NCOR1-
CC       dependent manner (By similarity). Negatively regulates the protein
CC       stability of NR3C1 and influences the time-dependent subcellular
CC       distribution of NR3C1, thereby affecting its transcriptional regulatory
CC       activity (By similarity). Plays a critical role in the circadian
CC       control of neutrophilic inflammation in the lung; under resting, non-
CC       stress conditions, acts as a rhythmic repressor to limit inflammatory
CC       activity whereas in the presence of inflammatory triggers undergoes
CC       ubiquitin-mediated degradation thereby relieving inhibition of the
CC       inflammatory response (By similarity). Plays a key role in the
CC       circadian regulation of microglial activation and neuroinflammation;
CC       suppresses microglial activation through the NF-kappaB pathway in the
CC       central nervous system (By similarity). Plays a role in the regulation
CC       of the diurnal rhythms of lipid and protein metabolism in the skeletal
CC       muscle via transcriptional repression of genes controlling lipid and
CC       amino acid metabolism in the muscle (By similarity).
CC       {ECO:0000250|UniProtKB:Q3UV55, ECO:0000269|PubMed:22425774}.
CC   -!- SUBUNIT: Binds DNA as a monomer or a homodimer (By similarity).
CC       Interacts with C1D, NR2E3, SP1 and ZNHIT1 (By similarity). Interacts
CC       with OPHN1 (via C-terminus) (PubMed:21874017). Interacts with PER2; the
CC       interaction associates PER2 to BMAL1 promoter region (By similarity).
CC       Interacts with CRY1 (By similarity). Interacts with CCAR2 (By
CC       similarity). Interacts with SIAH2 (By similarity). Interacts with FBXW7
CC       and CDK1 (By similarity). Interacts with HUWE1 (By similarity).
CC       Interacts with NR0B2 (By similarity). Interacts with NFIL3 (By
CC       similarity). Interacts (via domain NR LBD) with HSP90AA1 and HSP90AB1
CC       (By similarity). {ECO:0000250|UniProtKB:P20393,
CC       ECO:0000250|UniProtKB:Q3UV55, ECO:0000269|PubMed:21874017}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00407}.
CC       Cytoplasm {ECO:0000250|UniProtKB:Q3UV55}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q3UV55}. Cell projection, dendritic spine
CC       {ECO:0000250|UniProtKB:Q3UV55}. Note=Localizes to the cytoplasm,
CC       dendrites and dendritic spine in the presence of OPHN1. Localizes
CC       predominantly to the nucleus at ZT8 whereas it is cytoplasmic at ZT20.
CC       Phosphorylation by CSNK1E enhances its cytoplasmic localization.
CC       {ECO:0000250|UniProtKB:Q3UV55}.
CC   -!- INDUCTION: In bladder smooth muscle cells, exhibits night/day
CC       variations with a peak time at circadian time (CT) 4-12 and a trough at
CC       CT16-24. {ECO:0000269|PubMed:22549838}.
CC   -!- DOMAIN: Composed of three domains: a modulating N-terminal domain, a
CC       DNA-binding domain and a C-terminal ligand-binding domain.
CC   -!- PTM: Ubiquitinated, leading to its proteasomal degradation (By
CC       similarity). Ubiquitinated by the SCF(FBXW7) complex when
CC       phosphorylated by CDK1 leading to its proteasomal degradation (By
CC       similarity). Ubiquitinated by SIAH2; leading to its proteasomal
CC       degradation (By similarity). Rapidly ubiquitinated in response to
CC       inflammatory triggers and sumoylation is a prerequisite to its
CC       ubiquitination (By similarity). {ECO:0000250|UniProtKB:P20393,
CC       ECO:0000250|UniProtKB:Q3UV55}.
CC   -!- PTM: Sumoylated by UBE2I, desumoylated by SENP1, and sumoylation is a
CC       prerequisite to its ubiquitination. {ECO:0000250|UniProtKB:Q3UV55}.
CC   -!- PTM: Phosphorylated by CSNK1E; phosphorylation enhances its cytoplasmic
CC       localization. {ECO:0000250|UniProtKB:Q3UV55}.
CC   -!- PTM: Undergoes lysosome-mediated degradation in a time-dependent manner
CC       in the liver. {ECO:0000250|UniProtKB:Q3UV55}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR1
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA74939.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC062047; AAH62047.1; -; mRNA.
DR   EMBL; M25804; AAA74939.1; ALT_INIT; mRNA.
DR   PIR; A30226; A30226.
DR   RefSeq; NP_001106893.1; NM_001113422.1.
DR   RefSeq; NP_665718.2; NM_145775.2.
DR   AlphaFoldDB; Q63503; -.
DR   SMR; Q63503; -.
DR   IntAct; Q63503; 1.
DR   STRING; 10116.ENSRNOP00000012537; -.
DR   iPTMnet; Q63503; -.
DR   PhosphoSitePlus; Q63503; -.
DR   PaxDb; 10116-ENSRNOP00000012537; -.
DR   GeneID; 252917; -.
DR   KEGG; rno:252917; -.
DR   UCSC; RGD:628827; rat.
DR   AGR; RGD:628827; -.
DR   CTD; 9572; -.
DR   RGD; 628827; Nr1d1.
DR   eggNOG; KOG4846; Eukaryota.
DR   InParanoid; Q63503; -.
DR   OrthoDB; 3475284at2759; -.
DR   PhylomeDB; Q63503; -.
DR   Reactome; R-RNO-383280; Nuclear Receptor transcription pathway.
DR   PRO; PR:Q63503; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0000785; C:chromatin; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; ISS:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISO:RGD.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0070888; F:E-box binding; ISS:UniProtKB.
DR   GO; GO:0020037; F:heme binding; ISO:RGD.
DR   GO; GO:0004879; F:nuclear receptor activity; IBA:GO_Central.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; IDA:RGD.
DR   GO; GO:0001222; F:transcription corepressor binding; ISS:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0071347; P:cellular response to interleukin-1; ISS:UniProtKB.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; ISO:RGD.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; ISS:UniProtKB.
DR   GO; GO:0042632; P:cholesterol homeostasis; ISS:UniProtKB.
DR   GO; GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0007623; P:circadian rhythm; IEP:RGD.
DR   GO; GO:0060086; P:circadian temperature homeostasis; ISS:UniProtKB.
DR   GO; GO:0005978; P:glycogen biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0009755; P:hormone-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0001678; P:intracellular glucose homeostasis; ISS:UniProtKB.
DR   GO; GO:0061889; P:negative regulation of astrocyte activation; ISS:UniProtKB.
DR   GO; GO:0043124; P:negative regulation of canonical NF-kappaB signal transduction; ISS:UniProtKB.
DR   GO; GO:0120163; P:negative regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:1903979; P:negative regulation of microglial cell activation; ISS:UniProtKB.
DR   GO; GO:0150079; P:negative regulation of neuroinflammatory response; ISS:UniProtKB.
DR   GO; GO:0034144; P:negative regulation of toll-like receptor 4 signaling pathway; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0009648; P:photoperiodism; IEP:RGD.
DR   GO; GO:0070859; P:positive regulation of bile acid biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0042753; P:positive regulation of circadian rhythm; IDA:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0010498; P:proteasomal protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0031648; P:protein destabilization; ISS:UniProtKB.
DR   GO; GO:0042752; P:regulation of circadian rhythm; IDA:UniProtKB.
DR   GO; GO:0042749; P:regulation of circadian sleep/wake cycle; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0045598; P:regulation of fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:2000489; P:regulation of hepatic stellate cell activation; IDA:RGD.
DR   GO; GO:0061178; P:regulation of insulin secretion involved in cellular response to glucose stimulus; ISS:UniProtKB.
DR   GO; GO:0019216; P:regulation of lipid metabolic process; ISS:UniProtKB.
DR   GO; GO:0061469; P:regulation of type B pancreatic cell proliferation; ISS:UniProtKB.
DR   GO; GO:0044321; P:response to leptin; ISS:UniProtKB.
DR   CDD; cd07166; NR_DBD_REV_ERB; 1.
DR   Gene3D; 3.30.50.10; Erythroid Transcription Factor GATA-1, subunit A; 1.
DR   Gene3D; 1.10.565.10; Retinoid X Receptor; 1.
DR   InterPro; IPR035500; NHR-like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR050234; Nuclear_hormone_rcpt_NR1.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   PANTHER; PTHR24082; NUCLEAR HORMONE RECEPTOR; 1.
DR   PANTHER; PTHR24082:SF113; NUCLEAR RECEPTOR SUBFAMILY 1 GROUP D MEMBER 1; 1.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF57716; Glucocorticoid receptor-like (DNA-binding domain); 1.
DR   SUPFAM; SSF48508; Nuclear receptor ligand-binding domain; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Biological rhythms; Cell projection; Cytoplasm;
KW   Differentiation; DNA-binding; Heme; Iron; Metal-binding; Nucleus;
KW   Phosphoprotein; Receptor; Reference proteome; Repressor; Synapse;
KW   Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..615
FT                   /note="Nuclear receptor subfamily 1 group D member 1"
FT                   /id="PRO_0000053500"
FT   DOMAIN          285..615
FT                   /note="NR LBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01189"
FT   DNA_BIND        130..206
FT                   /note="Nuclear receptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         133..153
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         170..194
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   REGION          1..129
FT                   /note="Modulating"
FT   REGION          1..120
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1..70
FT                   /note="Required for phosphorylation by CSNK1E and
FT                   cytoplasmic localization"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UV55"
FT   REGION          49..285
FT                   /note="Crucial for activation of GJA1"
FT                   /evidence="ECO:0000250"
FT   REGION          235..287
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          312..337
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          357..385
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        248..264
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         419
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /evidence="ECO:0000250"
FT   BINDING         603
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         55
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000250|UniProtKB:P20393"
FT   MOD_RES         59
FT                   /note="Phosphoserine; by GSK3-beta"
FT                   /evidence="ECO:0000250|UniProtKB:P20393"
FT   MOD_RES         192
FT                   /note="N6-acetyllysine; by KAT5"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         193
FT                   /note="N6-acetyllysine; by KAT5"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         275
FT                   /note="Phosphothreonine; by CDK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UV55"
FT   MOD_RES         401
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P20393"
FT   MOD_RES         592
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P20393"
FT   CONFLICT        457
FT                   /note="H -> Q (in Ref. 2; AAA74939)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        550..551
FT                   /note="DR -> EG (in Ref. 2; AAA74939)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        565
FT                   /note="K -> E (in Ref. 2; AAA74939)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        569
FT                   /note="R -> G (in Ref. 2; AAA74939)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   615 AA;  66693 MW;  3CC44132F82A25F6 CRC64;
     MTTLDSNNNT GGVITYIGSS GSSPSRTSPE SLYSDSSNGS FQSLTQGCPT YFPPSPTGSL
     TQDPARSFGT VPPSLSDDSS PSSASSSSSS SSSSFYNGSP PGSLQVAMED SSRVSPSKGT
     SNITKLNGMV LLCKVCGDVA SGFHYGVHAC EGCKGFFRRS IQQNIQYKRC LKNENCSIVR
     INRNRCQQCR FKKCLSVGMS RDAVRFGRIP KREKQRMLAE MQNAMNLANN QLSSLCPLET
     SPAPHPTSGS VGPSPPPAPA PTPLVGFSQF PQQLTPPRSP SPEPTVEDVI SQVARAHREI
     FTYAHDKLGT SPGNFNANHA SGSPPATTPQ CWESQGCPST PNDNNLLAAQ RHNEALNGLR
     QGPSSYPPTW PSGPAHHSCH QPNSNGHRLC PTHVYSAPEG KAPANGLRQG NTKNVLLACP
     MNMYPHGRSG RTVQEIWEDF SMSFTPAVRE VVEFAKHIPG FRDLSQHDQV TLLKAGTFEV
     LMVRFASLFN VKDQTVMFLS RTTYSLQELG AMGMGDLLNA MFDFSEKLNS LALTEEELGL
     FTAVVLVSAD RSGMENSASV EQLQKTLLRA LRALVLKNRP SETSRFTKLL LKLPDLRTLN
     NMHSEKLLSF RVDAQ
//
